The ERISA Industry Committee sues to stop new Biden administration mental health regulations issued in 2024, saying they are “arbitrary and capricious” and employers cannot certify compliance “due to vague, undefined terms."
Various pieces of health care transparency legislation have identified areas requiring employers to meet their fiduciary responsibilities, such as designing an evaluation process for selecting vendors to deploy their health and welfare benefits strategy.
Medicare has announced 15 new drugs up for price negotiations, set to begin in the next several months with top drugmakers, including Pfizer, Novo Nordisk and GlaxoSmithKline.